Insider Selling: Mettler-Toledo International (NYSE:MTD) CFO Sells 800 Shares of Stock

Mettler-Toledo International, Inc. (NYSE:MTD) CFO Shawn Vadala sold 800 shares of the business’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the sale, the chief financial officer owned 5,288 shares in the company, valued at $7,456,714.56. This represents a 13.14% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Shawn Vadala also recently made the following trade(s):

• On Monday, November 24th, Shawn Vadala sold 1,025 shares of Mettler-Toledo International stock. The stock was sold at an average price of $1,452.00, for a total transaction of $1,488,300.00.
• On Tuesday, November 25th, Shawn Vadala sold 1,000 shares of Mettler-Toledo International stock. The shares were sold at an average price of $1,511.00, for a total transaction of $1,511,000.00.

Mettler-Toledo International Stock Down 0.2%

Shares of MTD traded down $2.61 during mid-day trading on Wednesday, reaching $1,397.72. 42,215 shares of the company’s stock were exchanged, compared to its average volume of 139,301. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,525.17. The company has a 50-day simple moving average of $1,419.25 and a two-hundred day simple moving average of $1,362.19. The company has a market cap of $28.42 billion, a price-to-earnings ratio of 33.17, a PEG ratio of 2.90 and a beta of 1.42.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share for the quarter, topping the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The company had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter last year, the business posted $12.41 earnings per share. Mettler-Toledo International’s revenue was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Hedge Funds Weigh In On Mettler-Toledo International

Several institutional investors and hedge funds have recently made changes to their positions in MTD. EverSource Wealth Advisors LLC lifted its position in shares of Mettler-Toledo International by 2.4% during the third quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock worth $361,000 after purchasing an additional 7 shares during the last quarter. Allworth Financial LP raised its stake in Mettler-Toledo International by 6.1% during the 3rd quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock valued at $149,000 after acquiring an additional 7 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Mettler-Toledo International by 1.6% in the third quarter. GAMMA Investing LLC now owns 510 shares of the medical instruments supplier’s stock worth $626,000 after purchasing an additional 8 shares during the period. Versant Capital Management Inc lifted its stake in shares of Mettler-Toledo International by 42.1% in the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after acquiring an additional 8 shares during the period. Finally, Valeo Financial Advisors LLC raised its holdings in Mettler-Toledo International by 4.0% during the third quarter. Valeo Financial Advisors LLC now owns 207 shares of the medical instruments supplier’s stock worth $254,000 after purchasing an additional 8 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Morgan Stanley lowered their target price on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research note on Tuesday. Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a research report on Monday, December 15th. Citigroup upped their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Finally, Stifel Nicolaus upped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $1,435.42.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.